Search Results - "Touw, Ivo P."

Refine Results
  1. 1

    G-CSF and its receptor in myeloid malignancy by Beekman, Renée, Touw, Ivo P.

    Published in Blood (24-06-2010)
    “…Granulocyte colony-stimulating factor (G-CSF) has been used in the clinic for more than 2 decades to treat congenital and acquired neutropenias and to reduce…”
    Get full text
    Journal Article
  2. 2

    RUNX1 Mutations in the Leukemic Progression of Severe Congenital Neutropenia by Olofsen, Patricia A, Touw, Ivo P

    Published in Molecules and cells (29-02-2020)
    “…Somatic mutations are found in approximately 10% of patients with acute myeloid leukemia (AML), but are more common in secondary forms of myelodysplastic…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia by Beekman, Renée, Valkhof, Marijke G., Sanders, Mathijs A., van Strien, Paulette M.H., Haanstra, Jurgen R., Broeders, Lianne, Geertsma-Kleinekoort, Wendy M., Veerman, Anjo J.P., Valk, Peter J.M., Verhaak, Roel G., Löwenberg, Bob, Touw, Ivo P.

    Published in Blood (31-05-2012)
    “…Severe congenital neutropenia (SCN) is a BM failure syndrome with a high risk of progression to acute myeloid leukemia (AML). The underlying genetic changes…”
    Get full text
    Journal Article
  5. 5

    Myeloid cells promote interferon signaling-associated deterioration of the hematopoietic system by Feyen, Jacqueline, Ping, Zhen, Chen, Lanpeng, van Dijk, Claire, van Tienhoven, Tim V. D., van Strien, Paulina M. H., Hoogenboezem, Remco M., Wevers, Michiel J. W., Sanders, Mathijs A., Touw, Ivo P., Raaijmakers, Marc H. G. P.

    Published in Nature communications (10-12-2022)
    “…Innate and adaptive immune cells participate in the homeostatic regulation of hematopoietic stem cells (HSCs). Here, we interrogate the contribution of myeloid…”
    Get full text
    Journal Article
  6. 6

    RUNX1 Mutations in the Leukemic Progression of Severe Congenital Neutropenia by Olofsen, Patricia A, Touw, Ivo P

    Published in Molecules and cells (2020)
    “…Somatic RUNX1 mutations are found in approximately 10% of patients with de novo acute myeloid leukemia (AML), but are more common in secondary forms of…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Granulocyte colony-stimulating factor and its receptor in normal myeloid cell development, leukemia and related blood cell disorders by Touw, Ivo P, van de Geijn, Gert-Jan M

    Published in Frontiers in bioscience (01-01-2007)
    “…Granulocyte colony-stimulating factor (G-CSF) is the major hematopoietic cytokine involved in the control of neutrophil production and thus serves as a…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Transcriptional reprogramming of CD11b+Esam(hi) dendritic cell identity and function by loss of Runx3 by Dicken, Joseph, Mildner, Alexander, Leshkowitz, Dena, Touw, Ivo P, Hantisteanu, Shay, Jung, Steffen, Groner, Yoram

    Published in PloS one (2013)
    “…Classical dendritic cells (cDC) are specialized antigen-presenting cells mediating immunity and tolerance. cDC cell-lineage decisions are largely controlled by…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Congenital neutropenia: disease models guiding new treatment strategies by Touw, Ivo P.

    Published in Current opinion in hematology (01-01-2022)
    “…Myeloid diseases are often characterized by a disturbed regulation of myeloid cell proliferation, survival, and maturation. This may either result in a severe…”
    Get full text
    Journal Article
  14. 14

    Analysis of Jak2 catalytic function by peptide microarrays: the role of the JH2 domain and V617F mutation by Sanz, Arturo, Ungureanu, Daniela, Pekkala, Tuija, Ruijtenbeek, Rob, Touw, Ivo P, Hilhorst, Riet, Silvennoinen, Olli

    Published in PloS one (18-04-2011)
    “…Janus kinase 2 (JAK2) initiates signaling from several cytokine receptors and is required for biological responses such as erythropoiesis. JAK2 activity is…”
    Get full text
    Journal Article
  15. 15
  16. 16

    The antioxidant protein peroxiredoxin 4 is epigenetically down regulated in acute promyelocytic leukemia by Palande, Karishma K, Beekman, Renee, van der Meeren, Lotte E, Beverloo, H Berna, Valk, Peter J M, Touw, Ivo P

    Published in PloS one (20-01-2011)
    “…The antioxidant peroxiredoxin (PRDX) protein family comprises 6 members, which are implicated in a variety of cellular responses, including growth factor…”
    Get full text
    Journal Article
  17. 17

    The JH2 domain and SH2-JH2 linker regulate JAK2 activity: A detailed kinetic analysis of wild type and V617F mutant kinase domains by Sanz Sanz, Arturo, Niranjan, Yashavanthi, Hammarén, Henrik, Ungureanu, Daniela, Ruijtenbeek, Rob, Touw, Ivo P., Silvennoinen, Olli, Hilhorst, Riet

    “…JAK2 tyrosine kinase regulates many cellular functions. Its activity is controlled by the pseudokinase (JH2) domain by still poorly understood mechanisms. The…”
    Get full text
    Journal Article
  18. 18

    B-cell tumor development in Tet2-deficient mice by Mouly, Enguerran, Ghamlouch, Hussein, Della-Valle, Veronique, Scourzic, Laurianne, Quivoron, Cyril, Roos-Weil, Damien, Pawlikowska, Patrycja, Saada, Véronique, Diop, M'Boyba K., Lopez, Cécile K., Fontenay, Michaela, Dessen, Philippe, Touw, Ivo P., Mercher, Thomas, Aoufouchi, Said, Bernard, Olivier A.

    Published in Blood advances (27-03-2018)
    “…The TET2 gene encodes an α-ketoglutarate–dependent dioxygenase able to oxidize 5-methylcytosine into 5-hydroxymethylcytosine, which is a step toward active DNA…”
    Get full text
    Journal Article
  19. 19

    Retroviral Insertion Mutagenesis in Mice as a Comparative Oncogenomics Tool to Identify Disease Genes in Human Leukemia by Touw, Ivo P, Erkeland, Stefan J

    Published in Molecular therapy (01-01-2007)
    “…Retroviral insertion mutagenesis has recently received much attention because of its adverse effects in the application of retroviral vector-based gene…”
    Get full text
    Journal Article
  20. 20

    The deubiquitinating enzyme DUB2A enhances CSF3 signalling by attenuating lysosomal routing of the CSF3 receptor by Meenhuis, Annemarie, Verwijmeren, Carola, Roovers, Onno, Touw, Ivo P

    Published in Biochemical journal (01-03-2011)
    “…Ubiquitination of the CSF3R [CSF3 (colony-stimulating factor 3) receptor] occurs after activated CSF3Rs are internalized and reside in early endosomes. CSF3R…”
    Get more information
    Journal Article